CD5E:SW:SW-Amundi Index Solutions - Amundi EURO STOXX 50 UCITS ETF-D EUR EUR (EUR)

ETF | Others |

Last Closing

USD 86.66

Change

0.00 (0.00)%

Market Cap

N/A

Volume

966.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-18 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
CHDIV:SW UBS ETF (CH) - MSCI Switzerlan..

+0.02 (+0.16%)

USD 1,244,681.59B
SWICHA:SW UBS ETF (CH) – MSCI Switzerl..

-0.16 (-0.72%)

USD 226,274.25B
SWUSAH:SW UBS ETF (CH) – MSCI Switzerl..

-0.22 (-0.74%)

USD 226,274.21B
SWEUAH:SW UBS ETF (CH) – MSCI Switzerl..

N/A

USD 226,274.20B
RGLDS:SW Raiffeisen ETF Solid Gold A US..

N/A

USD 134,034.93B
RGLDSH:SW Raiffeisen ETF Solid Gold H CH..

+17.00 (+0.29%)

USD 134,034.91B
RGLDOH:SW Raiffeisen ETF Solid Gold Ounc..

+8.80 (+0.49%)

USD 134,034.86B
RGLDO:SW Raiffeisen ETF Solid Gold Ounc..

+12.00 (+0.48%)

USD 134,034.85B
SPICHA:SW UBS ETF (CH) – SPI® (CHF) A..

-0.54 (-0.66%)

USD 131,872.43B
SPMCHA:SW UBS ETF (CH) – SPI® Mid (CH..

-1.68 (-1.40%)

USD 130,595.12B

ETFs Containing CD5E:SW

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.93% 91% A- 89% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.93% 91% A- 89% A-
Trailing 12 Months  
Capital Gain 15.47% 62% D 63% D
Dividend Return 2.90% 60% D- 58% F
Total Return 18.37% 69% C- 69% C-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 7.75% 65% D 66% D+
Dividend Return 8.01% 66% D+ 67% D+
Total Return 0.26% 61% D- 57% F
Risk Return Profile  
Volatility (Standard Deviation) 7.94% 55% F 60% D-
Risk Adjusted Return 100.94% 89% A- 90% A-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike